Mr. Aras Azadian reports

AVICANNA ANNOUNCES CLOSING OF ACQUISITION AND LAUNCH OF MYMEDI.CA

Avicanna Inc. has closed the previously announced acquisition of the Medical Cannabis by Shopper's business from Shoppers Drug Mart and has launched an all-new medical cannabis care platform, MyMedi.

Today, MyMedi.ca, a medical cannabis care platform, has officially launched nationwide in Canada. The platform's features include:

Medical Cannabis Marketplace: A diverse medical cannabis marketplace featuring approximately 200 unique products supplied by a network of 35 brands from various leading Canadian licensed producers.

Pharmacist-Led Patient Care Services: Pharmacist-led fully bilingual (English and French) patient care service programs including pharmacovigilance, compassionate pricing, and insurance adjudication in compliance with standards established by private and public payers.

Patient Education: Patient education programs and informational resources, including harm reduction strategies and risk mitigation.

Education for Healthcare Professionals: Medical education, training, and resources available to health care practitioners, hospitals, clinics, and institutions, along with potential collaboration opportunities, through the Company's Medical Affairs department

"We are pleased to have closed the acquisition of the Business from Shoppers Drug Mart(TM) and recognize this as a transformational milestone in the life of our Company. We would like to express our gratitude to the incredible network of collaborators who came together to ensure a smooth transition for the patients and deliver this medical platform that is adhering to required standards of patient privacy and care. We are motivated to meet the needs of our new patients through MyMedi.ca and welcome the thousands of patients that have transitioned over from the Medical Cannabis by Shoppers platform," stated Aras Azadian, CEO of Avicanna.

About Avicanna Inc.

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D and clinical development that has led to the commercialization of more than thirty products across various market segments: Medical Cannabis & Wellness Products ( RHO Phyto(TM)) : The formulary offers a diverse range of proprietary formulations including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids and is supported with ongoing patient, and medical community education. RHO Phyto has been established as a leading medical brand in Canada and is currently available nationwide to patients across several medical channels and continues to expand into new international markets.

Pharmaceutical Preparations and Pipeline : Leveraging Avicanna's scientific platform, vertical integration, and real-world evidence, Avicanna has developed an extensive a pipeline of patent-pending drug candidates that are indication-specific and in various stages of clinical development and commercialization. These cannabinoid-based drug candidates look to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders. Avicanna's first pharmaceutical preparation (Trunerox(TM)) is in the drug registration stage in South America.

MyMedi.ca Medical Cannabis Care : MyMedi.ca is Avicanna's medical cannabis care platform that is formed with the aim to better serve medical cannabis patients' needs and enhance the patient journey. MyMedi.ca features diverse and scientifically curated products from leading Canadian licensed producers in addition to pharmacist led patient support programs and educational resources to facilitate the incorporation of medical cannabis into health care regimens. MyMedi.ca also provides specialty services to distinct patient groups such as veterans and collaborating with public and private providers for adjudication and reimbursement.

We seek Safe Harbor.